In organs with diverse cell populations, it is not uncommon for one type of cell to respond while others are spared. Even in an organ with common cell types, such as hepatocytes within the liver, the population of cells may respond with different sensitivities for injury or for biochemical responses to toxicants. In the liver, many tumor promoters induce cytochrome P450 enzymes and other proteins in centrilobular cells at much lower doses than required to cause induction in periportal cells. In addition, these induction responses appear to occur at the level of individual cells-a 50% response of the liver for induction does not represent 50% induction in all cells. Instead, half of the cells are fully induced and half are unaffected. Cells "switch" from one phenotypic state to another. Over the past 10 years, several attempts have been made to model these cellular switches and to understand their relevance for hepatic tumor promotion and risk assessment. The data used for analyzing these switches include responses of the entire liver (total induction), responses of individual cells in the liver (regional induction), and cellular responses such as proliferation and apoptosis. This brief overview describes the development of biologically based, dose-respons e (BBDR) models for protein induction and tumor promotion in liver by 2,3,7,8-tetrachlorodibenzo -p-dioxin (TCDD) with emphasis on the role of speci c types of histological and molecular data in providing insights about mechanisms for cellular switches and their implications for tumor promotion. As the biological basis of these switches become unraveled and incorporated into the models, these BBDR models should eventually serve to improve risk assessments with a variety of liver tumor promoters with receptor-based modes of action.
INTRODUCTION
Dioxin, a potent hepatocarcinogen in female rats (13) , acts as a promoter rather than as an initiator in hepatic initiationpromotion assays (21) . Dioxin causes its biological effects through binding to a cellular protein, the Ah receptor (AhR) (22) . The AhR-dioxin complex serves as a transcription factor for multiple genes (26) . This receptor is normally found in a complex with several other proteins (20) . The binding of dioxin with the Ah receptor protein leads to dissociation of these other proteins from the original aggregate. The AhRdioxin complex then interacts with another protein, the Arnt protein (24) , to form a heterodimer that regulates transcription of cytochrome P450 1A1 by interacting at speci c upstream dioxin responsive elements-DREs (29) . The Ah receptor and Arnt are members of the basic-helix-loop-helix (b-HLH) family of proteins (10) .
The activation of sets of genes by dioxin is also believed to lead to pleiotropic responses including cell proliferation and differentiation. Although the mode-of-action of the AhRdioxin complex as a transcriptional activator is established in a general manner, it is unknown which of the genes or groups of genes affected by dioxin is responsible for toxicity or neoplasia. Induction of speci c cytochromes, cytochromes P450 1A1 and P450 1A2, in the liver of rodents has been regarded as a marker of the biological activity of dioxin; that is, at concentrations where dioxin induces these enzymes it is also expected to be capable of causing effects on other genes. Pharmacokinetic models that include induction have been developed to assess the exposure conditions that lead to increases in these cytochrome proteins in the liver (3, 14, 16) .
The response of the liver to dioxin is complex. At low doses of dioxin, induction of CYP1A1 and CYP1A2 occurs solely in the centrilobular region. At higher doses the area of induction extends further and further toward the periportal areas. In addition, there is a sharp boundary between unstained and fully stained cells when viewed by immunohistochemical techniques (5, 27; Figure 1 ). In dioxin-treated animals, individual hepatocytes appear to be either induced or noninduced. Out of necessity, the induction models used to date are simpli cations of the complex and incompletely understood biology of the Ah receptor dioxin complex and the manner in which the AhR-dioxin complex regulates suites of genes and initiates cellular level responses. These gene induction models utilize Hill equations in which induction of genes occurs due to an interaction of the AhR-dioxin complex with DREs (14, 23) . These simple models are hard to reconcile with coordinate regulation of batteries of genes or with the switching between phenotypic states of the hepatocytes.
Andersen et al (1) developed a pharmacokinetic model for regional induction that predicted heterogeneity in response throughout the liver predicated on presumed changes in AhRdioxin binding af nities in different regions of the liver. The goal of the PBPK/PD regional induction model was twofold: 1) to successfully describe regional differences in induction and 2) to link these gene induction responses to the dose response for tumor promotion (9) . These attempts to develop a BBDR model for hepatic tumor promotion by dioxin and the ongoing studies to improve the biological basis of these FIGURE 1.-Immunohistochemica l staining of CYP 1A1 and 1A2 in livers of rats treated subchronicall y with 2,3,7,8-tetrachlorodidenzo -p-dioxin. These data are from Tritscher et al (27) . The inclusion of these gures in the original Andersen et al (1) were with the kind permission of both the author and publisher. Rats, that had been initiated with diethylnitrosamine , were dosed biweekly at levels to give the following daily dose rates of 0, 3.5, 10.7, 35.7, and 125 nanograms /kg/day. Both CYP1A1 and CYP1A2 induction varied with dose. At the lowest daily doses, the CYP1A1 induction was primarily centrilobular and lled more and more of the liver acinar structures as dosage increased. models rely heavily on collection of quantitative histochemical and molecular data related to the processes of induction and promotion. The following sections outline some of the data that are required or that have been used in developing these BBDR models.
RESEARCH APPROACHES FOR STUDYING CELL SWITCHING
AND TUMOR PROMOTION Regional Induction-A Generic Response: Hepatic enzyme induction is a frequent response of several classical tumor promoters, such as dioxin, phenobarbital, and peroxisome proliferators (5, 7, 27) . Each of these compounds appears to interact via speci c receptors to coordinately regulate batteries of gene products in the liver. The nature of the receptors is different for these inducers. As noted above, dioxin works through the Ah receptor. Peroxisomal proliferator activating receptor (PPAR) proteins are members of the steroid hormone receptor super-family. These proteins contain zinc-nger DNA-binding motifs. Phenobarbital appears to act through a steroid family receptor, the CAR, that is, the constitutive androstenedione receptor (28) . Analysis of protein induction in the intact animal with so-called sigmoidal Emax models provides a measure of the nonlinearity of the induction response. Nonlinear threshold responses would have Hill-coef cients in these sigmoidal models of much greater than 1.0 (18); a Hill-coef cient of 1.0 is consistent with linear induction of the proteins. Whole liver Hill-coef cients for induction with phenobarbital are closer to 2.0 (25) . The best tting model with dioxin has a Hill-coef cient close to 1.0, indicating little nonlinearity. However, a very different picture emerges when induction is examined by immunohistochemical staining of liver tissues where individual cells seem to be either fully induced or remain in the basal state.
Models That Account for Induction and Regional Visualization:
The implications of regional induction were evaluated quantitatively by developing a geometric model for the liver acinus (1, 15) . The PBPK modeling in the intact liver was based on a geometric representation of the liver acinus with ve subcompartments. These 5 regions can be seen in Figure 2 . The acinus was geometrically divided into these 5 regions based on paths of least and paths of greatest distance between the periportal and the centrilobular regions of the liver. Of the 5 regions, the central 2 zones represent the region normally considered as the centrilobular (also referred to as the pericentral) region. They are the darkened regions in Panel A. The midzonal region, described by a single zone in the geometric subdivision of the liver, is the moderately shaded region in Panel B. The remaining portion of the liver corresponds to the periportal portions of the acinus. In contrast to the association of centrilobular and midzonal areas with individual acini, the periportal zone spreads diffusely through the entire liver. The model for induction of CYP1A1/2 by TCDD was developed as an extension of previous TCDD models that examined TCDD concentrations and protein induction (3, 14) . Protein induction was included via binding of TCDD to the Ah receptor and subsequent binding of the Ah-TCDD complex to dioxin response elements (DREs) associated with the promoter region of the induced genes. The enhanced rate of transcription of the CYP genes was proportional to the occupancy of the DRE by the Ah-TCDD complex.
The simulation of the intensity of regional staining required a 2-step process. First, the PBPK/gene induction model calculated the extent of induction of the CYP1A1 and A2 proteins in each region. The induction was compared to the maximum induction that could be achieved to give a maximum proportion of induction in each region. Then, the maximum induction was converted to color intensity and mapped to the respective regions of the acinus. This calculation permitted depiction of induction as shown in Figure 2 and comparison with laboratory data as shown in Figure 1 . To describe the differential responses between the 5 regions, the apparent binding constants (Kds) for the interaction of the Ah receptor-TCDD with the DNA-DRE were systematically varied for the 5 zones. To t the dose-response of regional induction and the all-or-none response of individual hepatocytes required changing Kds by a factor of 3 between each region and use of Hill-coef cients of 4 to 5 in each of the regions. Thus, when considering regional induction, the observed responses are, in fact, highly nonlinear. The cells most sensitive to induction are found in the centrilobular region. Induction of these cells provides information regarding the lowest concentration of TCDD and Ah receptor capable of switching hepatocytes from a basal state to the TCDD-induced phenotype. The dose dependence of induction in the centrilobular region has been proposed for use as the basis for risk assessment calculations in a threshold model for responses to these liver tumor promoters. Mechanistic risk assessments for dioxin, however, require more knowledge of the relationship between protein induction/cell switching and cellular level responses, that is, mutation, proliferation, and apoptosis, as they relate to cancer causation. The relationship between induction and promotion has been examined in BBDR models for this endpoint; the mechanistic basis of the switching phenomenon requires application of new methods in molecular toxicology. Both these areas are discussed below. (8) have worked to link the regional protein induction model with a quantitative model for tumor induction. Dioxin produced a U-shaped, dose-response curve for cell proliferation rates in total liver (17) and for promotion of altered hepatic foci in female Sprague-Dawley rats (21) initiated with a combination of partial hepatectomy and diethylnitrosamine (DEN) treatment. Both volume fraction and number of foci/liver were reported to be below control at 0.0001 and 0.001 mg/kg/day and greater than control at 0.01 and 0.1 mg/kg/day. Because the cells in altered foci are thought to be at an intermediate stage between normal and malignant, this observation raises the possibility that some levels of exposure to dioxin may be associated with a liver cancer risk below the risk in controls (2) . Such interpretations of the data on growth of preneoplastic foci and their implications for risk assessment must be made cautiously, however, and should be guided by an understanding of the mechanisms giving rise to the U-shaped curve.
Linking Regional Induction with Models for Tumor Promotion: Conolly and Andersen
Jirtle et al (11) proposed a negative selection mechanism for hepatic tumor promotion by phenobarbital. Andersen et al (4) suggested that this mechanism might be broadly applicable to a diverse group of liver tumor promoters, including dioxin. In negative selection, the promoter rst provides a mitogenic stimulus to hepatocytes. Then, the liver elaborates mitosuppressant growth factors to constrain proliferation. Finally, speci c cells, mutated at loci that render them insensitive to the mito-inhibitory environment, derive a growth advantage and grow out to altered foci that eventually progress to tumors. With phenobarbital, transforming growth factor b 1 is the inhibitory growth factor. Mutations in the mannose-6-phosphate receptor that binds and activates TGF-b 1 appear to be responsible for rendering cells unresponsive to TGF-b 1 (12) . Ohno et al (19) demonstrated that pericentral-equivalent hepatocytes were more sensitive to TGF-b 1 -induced apoptosis than were periportal-equivalent hepatocytes.
Andersen and colleagues (3, 4) advocated the idea that TCDD also acts via a negative selection mode-of-action on rodent liver. The U-shaped curve could be explained as arising from the presence of at least 2-initiated cell populations, one type of mutated cell would be responsive to mito-inhibition related to low-dose promoter treatment, the second mutated cell type would be unresponsive to mito-inhibition and grow out to clones of altered cells over time. A differential sensitivity to the effects of dioxin on each of these cell populations would give rise to the U-shaped curves (8) .
An empirical, quantitative analysis of the U-shaped curve for TCDD attempted to evaluate the relationship of regional induction with the U-shaped behavior seen for cell proliferation and for growth of the hepatic altered foci. A simulation model based on that by Conolly and Kimbell (9) was used to evaluate alternative hypothesis about the respective roles of partial hepatectomy, DEN initiation, and TCDD promotion in development of the U-shaped curve. The results of the simulation model (Figure 3 ) provided a picture of the dose-and time-dependence of foci formation for dioxin. The downward going region of the U-shaped, dose-response curve, apparent at 170 days of treatment in these simulations, is associated with induction in only a very small percentage of the centrilobular region. The upward going portion of the U-shaped curve with clear promotional response was more closely associated with the doses that provided induction in the midzonal and periportal regions of the liver. It is also of interest that proliferation in the liver, although not increased compared to untreated controls, was primarily periportal in dioxin-treated livers, indicating that the induced portions of the liver, the centrilobular zones, have lower proliferation rates. Although further quantitative studies are necessary to evaluate the exact relationships of extent of induction with adverse consequences of exposure, the association of quantal responses-that is, cell-level induction, proliferation or apoptosis-with dioxin exposure needs to supplant descriptions that focus primarily on graded responses at the whole organ level. (8) . As time progresses, the simulated curves become U-shaped. This shape arises in these simulations from the assumption that there are 2 types of initiated cells formed from initiation following the DEN/partial hepatectomy treatment. One of these cell types is sensitive to mito-suppressant cell environmen t caused by the promoter. These cells die off at low concentration s of dioxin and provide the downward-slope d section of the dose response curve at low doses. The upward-going section is related to a group of cells that resist the mito-suppresive environmen t and grow out to identi able clones at the higher doses. The dose range modeled correspond s to the range evaluated by Pitot et al (21) .
SUMMARY AND FUTURE DIRECTIONS
In the absence of quanti cation of these induction responses on the cellular level and of a clearer understanding of the biological mechanisms of these cell switches, there is understandable regulatory resistance to using highly nonlinear risk assessment models for these receptor-mediated responses. Short-term in vivo or in vitro methods should become a critical adjunct to more thoroughly characterize 'switching' responses for a variety of tumor promoters. Two approaches are likely to provide important data for more complete characterization of the biology of these cellular responses. The rst promising approach is laser capture microdissection (LCM) of cells from induced areas of the liver and evaluation of the genomic and proteomic alteration in these cells. Preferably, studies should be done on time course and dose-response of the control of genes and gene products that are involved in these effects, including receptor genes, the CYP proteins, and kinases involved in cell signaling/replication. With LCM, a challenge is to identify the regions of the liver that have responded and target them for careful study. Such a research program would require a large number of animals and signi cant investment in personnel costs for staining, identifying, and obtaining the altered cells for study from intact animals.
We are pursuing studies in primary hepatocyte cultures where it is easier to collect time course and dose-response/ time course information for gene/gene products while using a minimum number of animals for the studies. Previous studies have established that hepatocytes in vitro also respond with an all-or-none pattern of induction (6) . These systems should allow more mechanistic examinations of the switching process and coupled with studies in the intact animal permit evaluation the biological and pathological consequences of these responses. Ultimately, the combination of in vitro and in vivo studies will be necessary to provide a biologically based dose-response (BBDR) model capable of supporting interspecies and low dose extrapolations required for risk assessment with these compounds. Quantitative histochemical and molecular data will have to be integrated with emerging BBDR models to generate novel risk assessment methods justi ed on mechanistic grounds.
